Targeted Exosome Loading via Fusion Protein RNA Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies lack control over which molecules are loaded into exosomes, making it difficult to efficiently load specific RNA species, particularly for therapeutic applications such as gene therapy and stem cell reprogramming.

Innovation Solution

The development of a Targeted And Modular Exosome Loading (TAMEL) system, which uses a fusion protein with an RNA-binding domain and an exosome-targeting domain to specifically package and deliver cargo RNA into exosomes, independent of natural loading mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If natural exosome loading mechanisms are used, then exosomes are produced with endogenous RNA cargo, but control over which specific RNA species are loaded is lost

Engineering Contradiction:
Improvecontrol over RNA species loadingVSAvoidloading system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent introduces an artificial RNA-binding protein as an intermediary component that mediates between the exosome and the target RNA species. This protein contains an RNA-binding domain that specifically recognizes and binds to the cargo RNA, and an exosome-targeting domain that directs the complex to exosomes. This intermediary enables precise control over which RNA species are loaded into exosomes without relying on natural, non-specific loading mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite structure by fusing the RNA-binding domain and exosome-targeting domain into a single chimeric protein. This composite protein combines the specific RNA recognition capability of bacteriophage coat proteins with the exosome-targeting capability of lysosomal membrane proteins (such as LAMP2b), enabling simultaneous RNA binding and exosome targeting in one molecule.

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If specific RNA species are targeted for loading, then therapeutic delivery precision is improved, but the efficiency of loading certain RNA species remains insufficient

Engineering Contradiction:
ImproveRNA species selection precisionVSAvoidRNA loading efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent performs preliminary action by engineering the cargo RNA to contain a specific binding motif (such as an MS2 stem-loop structure) that is recognized by the RNA-binding domain of the artificial protein. This pre-engineering of the RNA with the binding motif ensures that when the artificial protein is expressed in the cell, it can immediately and efficiently capture and direct the specific RNA species into exosomes, greatly enhancing loading efficiency for targeted RNA species.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If exosomes are used for therapeutic delivery, then cellular uptake and targeting capability are achieved, but control over cargo composition is limited

Engineering Contradiction:
Improvetarget cell delivery capabilityVSAvoidcargo RNA composition control
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent creates a universal system that can deliver multiple different types of cargo RNA (mRNA, miRNA, shRNA, etc.) using the same artificial protein platform. By changing only the RNA-binding domain's specificity or the cargo RNA's binding motif, the same exosome delivery vehicle can be programmed to carry different therapeutic RNA species, maintaining the natural exosome uptake advantages while gaining precise cargo control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise control over the RNA species in exosomes, allowing for the efficient delivery of therapeutic RNAs to target cells, enhancing the therapeutic utility of exosomes for gene therapy, vaccines, and stem cell reprogramming.

Implementation Method 1

the RNA-binding domain binds specifically to the RNA-motif on the cargo RNA

Methodology Applied
Scientific EffectMolecular recognition:

Implementation Method 2

The exosome-targeting domain sorts the fusion protein into exosomes

Methodology Applied
Scientific EffectEndosomal sorting:

Data Source

PatentUS10538570B2Targeted and modular exosome loading system
Publication Date: 2020.01.21 NORTHWESTERN UNIV
  • US10538570B2 patent drawing
  • US10538570B2 patent drawing
  • US10538570B2 patent drawing

AI summary

Disclosed are exosomes that include a packaging protein and a cargo RNA in which the packaging protein binds specifically to the cargo RNA. The packaging protein is a fusion protein that includes an RNA-binding domain and an exosome-targeting domain. The cargo RNA includes an RNA-motif that the RNA-binding domain of the fusion protein binds specifically such that the cargo RNA is packaged in the lumen of the exosomes.